Research, price information & chart analysis

Roadmap Feature *brandnew*: ThemeFolios

In this section, we provide users of our information portal with a further, now very extensive option for carrying out research and analyses on listed companies. The module offers a wide range of setting options as well as a number of useful additional features that make your work easier when analyzing companies. You also save valuable time, as further information is just a click away.

The intelligent search function allows you to search by WKN, ISIN, symbol or the name of the company. The database is constantly being expanded. If you would like to refer to a specific chart, you are welcome to use the short URL provided. With one click you can copy it to the clipboard and link it via e-mail or social media. The integrated AI provides you with further information on the individual companies. Simply click on the small OpenAI symbol and wait for the result of the AI analysis. Tip: Switch to the *Advanced version* to display the professional view of the charting.

Tool Partner

This overview is updated on an ongoing basis. It shows the companies for which news is available from selected stock exchange operators - in this case NASDAQ Nordic via GlobeNewsWire. This may include corporate actions, information on dividends, but also products and many other types of company-relevant information. If you are in the chart view (360°), you can easily jump from there to the respective news item and carry out further research. All news across products and events can be found in the X-Feed Billboard (International).

NEWS
EXPLORER
Tue, 18.06.2024

FORM 8.5 (EPT/RI)

Silent Ad
Tue, 18.06.2024       Alvotech
LU2458332611

REYKJAVIK, Iceland and LONDON, June 18, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the companies have entered into an exclusive partnership agreement regarding the supply and commercialization of Alvotech’s proposed biosimilar to Eylea® (aflibercept). Alvotech is currently developing AVT06, a proposed biosimilar to Eylea® low dose (2 mg) and AVT29, a biosimilar candidate for Eylea® high dose (8 mg).

Silent Ad
Tue, 18.06.2024

FORM 8.5 (EPT/RI)

Silent Ad
Tue, 18.06.2024       Alvotech
LU2458332611

REYKJAVIK, ICELAND and LONDON, UK (June 18, 2024) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the companies have entered into an exclusive partnership agreement regarding the supply and commercialization of Alvotech’s proposed biosimilar to Eylea® (aflibercept). Alvotech is currently developing AVT06, a proposed biosimilar to Eylea® low dose (2 mg) and AVT29 a biosimilar candidate for Eylea® high dose (8 mg).

Silent Ad
Tue, 18.06.2024       Nokia
FI0009000681

Press release
Nokia and Google Cloud collaborate to help developers worldwide create 5G applications faster with telco APIs

Silent Ad
Tue, 18.06.2024

FORM 8.5 (EPT/RI)

Silent Ad
Tue, 18.06.2024       Nxera Pharma
JP3431300007

Tokyo, Japan and Cambridge, UK, 18 June 2024 – Nxera Pharma (“Nxera” or “the Company”; TSE 4565), today announces the publication of its Annual Report and its Environment, Social & Governance (ESG) Report for the year ended 31 December 2023.

Silent Ad
Tue, 18.06.2024

FORM 8.5 (EPT/RI)

Silent Ad
Tue, 18.06.2024       Shanghai Junshi Biosciences
CNE100003FF7

SHANGHAI, June 18, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has approved the supplemental new drug application (sNDA) for toripalimab (product code: JS001) in combination with etoposide plus platinum for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC).

Silent Ad
Shanghai Junshi Biosciences
Tue, 18.06.2024       NewHydrogen
US6514511061

Noted Economist Gordon Rausser elaborates on investment strategies in the growing green hydrogen market

Silent Ad
Tue, 18.06.2024
999999999999

Stockholm, 2024-06-18

Silent Ad
Tue, 18.06.2024       Aalborg Boldspilklub
DK0060868966

NASDAQ Copenhagen A/S

Silent Ad
Tue, 18.06.2024       Svitzer Group
DK0062616637

Halifax, NS 18 June 2024 Atlantic Towing Limited, a member of the J.D. Irving, Limited family of companies and Svitzer have made a significant joint investment in the modernisation of the Port of Halifax fleet by acquiring two new escort tugboats from the Rastar 3200 series, each boasting an 85-ton bollard pull.

Silent Ad
Tue, 18.06.2024       Signify
NL0011821392

Tue, 18.06.2024       Meriaura
FI4000425848

Meriaura Group Plc
Company announcement, Major holdings                            18.6.2024 klo 9.00 (CEST)

Silent Ad
Tue, 18.06.2024
DK0015773873

Der anmodes om ophør af suspension for afdelinger nedenfor.

Silent Ad
Tue, 18.06.2024       Cheops Technology
FR0010447086


CHEOPS TECHNOLOGY 
FRANCHIT LE CAP DES 200 MILLIONS D’EUROS DE CHIFFRE D’AFFAIRES CONSOLIDÉ

Silent Ad
Tue, 18.06.2024       Clean Motion
SE0008216303

Clean Motion meddelade den 13 juni 2024 att de har tecknat en avsiktsförklaring om ett förvärv av EVX Mobility Sweden AB genom en apportemission. Förvärvet ses som strategiskt för att stärka Clean Motions position på marknaden för lätta elfordon då det breddar bolagets sortiment med större fyrhjuliga fordon. Förvärvet accelererar företagets tillväxtplaner genom marknadsintroduktion av bland annat arbetsfordon och fordon för hotell, park och resorts, på flera nya marknader. Förvärvet adderar flera nya försäljningsklara fordonsmodeller och man ser att förvärvet kommer generera korsförsäljning till gemensamma såväl som nya kunder inom alla produktkategorier. Clean Motion ser att detta förvärv förväntas generera ett avsevärt aktieägarvärde och intäkter i närtid. Prognosen för orderingången på EVX-fordonsmodeller 2024 är 36 miljoner kronor samt 260 miljoner kronor för 2025.

Silent Ad
Tue, 18.06.2024       Euronext
NL0006294274

René van Vlerken to succeed Simone Huis in ‘t Veld as CEO of Euronext Amsterdam

Silent Ad
Tue, 18.06.2024       Spar Nord Bank
DK0060036564

In company announcement no. 10 2024, Spar Nord announced a share buyback programme of up to DKK 500 million. The share buyback was initiated on 12 February 2024.

Silent Ad

Notes on the functional elements

  • Research - Shows the price history as a graph and enables access to a wide range of additional information
  • About - AI-generated company profile
  • Factsheet - Company profile of the most important stock exchange-specific identification parameters (ISIN, ticker...).)
  • Website - Allows you to access the website of the selected security
  • Bookmark - Allows you to set up and add securities to a virtual portfolio
  • News - Link to the latest news
  • CFD - If tradable as a contract for difference, Possibility to test this in a demo version
  • K/V - Possibility to trade the selected product with a financial service provider (in development)

Badge 'News Explorer' - Functional element to open navigation panel

New power feature: Developed for publishers, stock market editors, journalists - With the new AiO Extender you can access the entire news timeline quickly and conveniently.